Research for 2012

Market Commentary December 2012


Please find this month's Market Commentary newsletter which contains our view on the stock market based upon fundamental and technical analysis along with some recommended investments for the current market. Last month's market forecast was spot on with the market rising 0.9% following our posit [...]

Sell AstraZeneca / Buy GlaxoSmithKline


Today, we are recommending our clients to sell AstraZeneca ("Astra") and switch into GlaxoSmithKline ("Glaxo"). AstraZeneca has had a good run as late, rising from 2792p to its current 3024p share price in just two months (a 8.3% gain). Though we originally switched from Glaxo into Astra, this ca [...]